News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Xiuning Le: Presented Dato-DXd with Osimertinib in EGFR-Refractory NSCLC Patients at ELCC25
Xiuning Le/X
Mar 29, 2025, 19:01

Xiuning Le: Presented Dato-DXd with Osimertinib in EGFR-Refractory NSCLC Patients at ELCC25

Xiuning Le, Associate Professor at MD Anderson Cancer Center, shared a post on X:

“A very successful ELCC25 I presented Dato-DXd (4mg/kg vs 6mg/kg) with osimertinib in EGFR refractory NSCLC patients, from ORCHARD trial. mPFS 11.7 mon and ORR 36% in Dato-DXd 6mg/kg cohort.

Improving upon what we have and explore new combinations. ”

Xiuning Le: Presented Dato-DXd with Osimertinib in EGFR-Refractory NSCLC Patients at ELCC25

More posts featuring ELCC25.

cancer ELCC25 Lung cancer NSCLC OncoDaily Oncology ORCHARD trial Xiuning Le
Special Coverage
Voices
Aug 17, 2025, 08:01
Niranjala Siriwardena: The Hidden Work of Advocating for Your Rights After Cancer
Science
Aug 17, 2025, 07:56
Doan Ngo: A Big Year for Newcastle Centre of Excellence in Cardio-Oncology! 
Voices
Aug 17, 2025, 07:42
Joeanne Wong: Real Progress Comes When We Build the Right Culture
Voices
Aug 17, 2025, 07:33
Christopher Clinton Conway: The Hallmark of Good Nonprofit Leadership - Planning Your Own Transition
Science
Aug 17, 2025, 07:26
Himanshu Mishra: DNASE1L3-Driven NET Degradation Boosts Immunotherapy Efficacy
Voices
Aug 17, 2025, 07:15
David Zaas: No Better Way to End the Week
Voices
Aug 17, 2025, 07:09
Ed Kim: Ensuring Greater Access to City of Hope’s Care and Clinical Trials
Blog Posts
Aug 17, 2025, 06:59
Last Chance: Early Bird Registration for SIOG2025 Ends in 1 Month
Stories
Aug 17, 2025, 06:50
Abraham Adamu: Knowing the Disease, But Not How to Speak
Science
Aug 17, 2025, 06:39
Zacharoula Sidiropoulou: AI Processes Data. Humans Process Life
Science
Aug 17, 2025, 06:31
Aaron Sverdlov: Can An Established Anticancer Drug Also Protect the Heart from Chemotherapy-Induced Cardiotoxicity?
Blog Posts
Aug 17, 2025, 06:18
At an Age When Most Kids Learn to Read, Annabelle Learns to Share Her Cancer Journey - St. Baldrick's Foundation